v3.26.1
The company - Additional Information (Details)
€ in Thousands
12 Months Ended
Dec. 31, 2025
EUR (€)
subsidiary
Approach
Dec. 31, 2024
EUR (€)
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Company Information [Line Items]        
Number of therapeutic approaches | Approach 3      
Net loss for the period € 49,177 € 49,471 € 7,570  
Total equity € (21,704) € 8,834 € 51,901 € 54,151
Number of subsidiaries | subsidiary 1